Logo-japid
Submitted: 12 Jul 2020
Revision: 12 Aug 2020
Accepted: 15 Aug 2020
ePublished: 10 Dec 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Adv Periodontol Implant Dent. 2020;12(2): 59-63.
doi: 10.34172/japid.2020.012
  Abstract View: 289
  PDF Download: 134

Original Article

Evaluation of salivary calcium, phosphorus and alkaline phosphatase concentrations before and after the first phase of periodontal treatment in patients with chronic periodontitis

Jaber Yaghini ORCID logo, Samaneh Khashei, Zohreh Afshari ORCID logo, Ahmad Mogharehabed* ORCID logo

Abstract

Background. Evaluation of salivary biomarkers is a non-invasive, convenient, and economical method for diagnosing many diseases. Evidence shows that salivary biomarkers and periodontal disease might be correlated. This study was conducted to evaluate phase I periodontal therapy’s effect on salivary concentrations of calcium, phosphorous, and alkaline phosphatase (ALP).
Methods. In this descriptive, analytical study, 16 patients were selected from those referred to the Department of Oral Medicine, Faculty of Dentistry, Isfahan University of Medical Sciences, using convenience sampling. Salivary samples were collected using the drooling method. The salivary concentrations of calcium, phosphorous, and ALP were measured immediately after saliva collection, before the first phase of periodontal therapy and one month later, using a colorimetric assay. The data were analyzed with SPSS using paired t-test. P<0.05 was considered statistically significant.
Results. The salivary concentrations of calcium, phosphorous, and ALP were 6.68, 20.57, and 48.31 mg/dL, respectively, before and 7.15, 22.51, and 40.37 mg/dL, respectively, after phase I periodontal therapy. There were no significant differences between the salivary levels of calcium, phosphorous, and ALP before and after phase I periodontal therapy (P>0.05).
Conclusion. This study revealed that the salivary concentrations of calcium, phosphorous, and ALP remained relatively unchanged after phase I periodontal therapy.
Keywords: Alkaline phosphatase, Calcium, Calcium, Periodontal disease, Phosphorus, Saliva
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 229

Your browser does not support the canvas element.


PDF Download: 134

Your browser does not support the canvas element.